Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular LymphomaDaniela Drandi, Marco Ladetto, Giorgio Inghirami et al.|Journal of Molecular Diagnostics|2015Cited by 132
Prospective molecular monitoring of minimal residual disease after non-myeloablative allografting in newly diagnosed multiple myelomaMarco Ladetto, Benedetto Bruno, Simone Ferrero et al.|Leukemia|2015Cited by 36
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genesSimone Ferrero, Marco Ladetto, Daniela Capello et al.|Haematologica|2011Cited by 16
Radioimmunotherapy in relapsed/refractory mantle cell lymphoma patients: final results of a European MCL Network Phase II TrialSimone Ferrero, Alessandro Pastore, Christian W. Scholz et al.|Leukemia|2015Cited by 12
LONG-TERM RESULTS of the GIMEMA VTD Consolidation TRIAL In Autografted MULTIPLE Myeloma PATIENTS (VEL-03-096): IMPACT of Minimal RESIDUAL DISEASE Detection by REAL Time Quantitative PCR On LATE Recurrences and Overall SURVIVALMarco Ladetto, Antonio Palumbo, Simone Ferrero et al.|Blood|2011Cited by 9